We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Printed Implant Helps Regenerate the Meniscus

By HospiMedica International staff writers
Posted on 22 Dec 2014
A personalized three dimensional (3-D)-printed scaffold infused with human growth factors can prompt the body to regenerate the meniscus. More...


Researchers at Columbia University (New York, NY, USA), the Hospital for Special Surgery (HSS; New York, NY, USA), and Cornell University (Ithaca, NY, USA) first performed magnetic resonance imaging (MRI) scans of an intact meniscus in an undamaged knee. The scans were then converted into a 3-D image which was used to drive a 3-D printer, producing a scaffold in the exact shape of the meniscus, down to a resolution of 10 microns. The scaffold was made of polycaprolactone, a biodegradable polymer that is also used to make surgical sutures.

The scaffold was then infused with two recombinant human proteins: connective growth factor (CTGF) and transforming growth factor β3 (TGFβ3); the delivery of the two proteins attracted existing stem cells from the body and induced them to form meniscal tissue, when released in specific areas of the scaffold in a specific sequential order. This was accomplished by encapsulating the proteins in slow-dissolving polymeric microspheres, first releasing CTGF (to stimulate production of the outer meniscus) and then TGFβ3 (to stimulate production of the inner meniscus).

Finally, the protein-infused scaffold was tested by inserting the scaffold in 11 sheep (whose knee closely resembles that of humans). The animals were randomized to have their meniscus replaced with a protein-infused 3-D scaffold, replacing the surgically removed natural meniscus. The meniscus regenerated in about four to six weeks, and after three months, the treated animals were walking normally. In a postmortem analysis, the regenerated meniscus had structural and mechanical properties very similar to those of natural meniscus. The study was published online on December 10, 2014, in Science Translational Medicine.

“This is a departure from classic tissue engineering, in which stems cells are harvested from the body, manipulated in the laboratory, and then returned to the patient, an approach that has met with limited success,” said lead author Jeremy Mao, DDS, PhD. “In contrast, we're jumpstarting the process within the body, using factors that promote endogenous stem cells for tissue regeneration. We envision that personalized meniscus scaffolds, from initial MRI to 3-D printing, could be completed within days.”

According to the researchers, the therapy could provide the first effective and long-lasting repair of damaged menisci, which occur in millions of people each year and can lead to debilitating osteoarthritis.

Related Links:

Columbia University
Hospital for Special Surgery
Cornell University



Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image: Tubes attached to this artificial lung are connected to the patient\'s neck or chest, allowing blood to circulate and get oxygen while the patient is conscious. (Image Credit: Carnegie MellonImage: Tubes attached to this artificial lung are connected to the patient\'s neck or chest, allowing blood to circulate and get oxygen while the patient is conscious. (Image Credit: Carnegie Mellon University)University)

Portable Artificial Lung Technology Could Reshape Care for Chronic Lung Disease

Chronic lung disease can leave patients dependent on prolonged mechanical ventilation or awaiting transplantation, both of which carry substantial morbidity and healthcare costs. Ventilatory support may... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.